Press Releases Applied DNA Sciences, Inc. BOERSE MUENCHEN

Equities

UDJ

US03815U4094

Real-time BOERSE MUENCHEN Other stock markets 03:43:42 01/07/2024 pm IST			5-day change	1st Jan Change
0.414 ^EUR	0.00%		-0.48%	-96.49%

20/06	Applied DNA Sciences, Inc. and Alphazyme LLC Conclude Linea (TM) RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea (TM) IVT Platform Economics	CI
18/06	Applied DNA Partners With GenXys For Pharmacogenetic Testing	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Applied DNA and Alphazyme Conclude Linea RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea IVT Platform Economics	21/06	AQ
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic Testing	19/06	AQ
Applied DNA Sciences : Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing	18/06	PU
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea IVT Platform	06/06	AQ
Applied DNA Announces Pricing of $12 Million Public Offering	29/05	AQ
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement	13/05	AQ
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot	11/05	AQ
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program	26/04	AQ
Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress	15/03	AQ
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot	09/02	AQ
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	01/02	AQ
Applied DNA Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow	15/12	AQ
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot	08/12	AQ
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023	06/12	AQ
Applied DNA Extends Application of Linea IVT Platform to saRNA	17/11	AQ
Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production	24/23/24	AQ
Applied DNA Sciences: Fiscal Q3 Earnings Snapshot	11/23/11	AQ
Conference Call/Webcast Scheduled for Today at 4:30 PM ET - Form 8-K	11/23/11	PU
Applied DNA Biotherapeutics Subsidiary LineaRx to Participate in Upcoming mRNA Industry Conferences	19/23/19	AQ
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot	12/23/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Applied DNA Sciences, Inc. BOERSE MUENCHEN

Equities

UDJ

US03815U4094

Press Releases

Filters